These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 22872786)

  • 21. The pharmacological approach to reverse portal hypertention and hepatic schistosomal fibrosis in Egypt, control experimental study.
    Helmy AH; Abdel-Hady AA; el-Shanawany F; Hammam O; Abdel-Hady A
    J Egypt Soc Parasitol; 2005 Dec; 35(3):731-50. PubMed ID: 16333884
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combined antiretroviral therapy attenuates hepatic extracellular matrix remodeling in HIV patients assessed by novel protein fingerprint markers.
    Leeming DJ; Anadol E; Schierwagen R; Karsdal MA; Byrjalsen I; Nielsen MJ; Schwarzer-Zander C; Boesecke C; Bendtsen F; Møller S; Strassburg CP; Spengler U; Krag A; Rockstroh J; Trebicka JK
    AIDS; 2014 Sep; 28(14):2081-90. PubMed ID: 25136933
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel assay for extracellular matrix remodeling associated with liver fibrosis: An enzyme-linked immunosorbent assay (ELISA) for a MMP-9 proteolytically revealed neo-epitope of type III collagen.
    Barascuk N; Veidal SS; Larsen L; Larsen DV; Larsen MR; Wang J; Zheng Q; Xing R; Cao Y; Rasmussen LM; Karsdal MA
    Clin Biochem; 2010 Jul; 43(10-11):899-904. PubMed ID: 20380828
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protein degradation fragments as diagnostic and prognostic biomarkers of connective tissue diseases: understanding the extracellular matrix message and implication for current and future serological biomarkers.
    Genovese F; Karsdal MA
    Expert Rev Proteomics; 2016; 13(2):213-25. PubMed ID: 26689914
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel marker for assessment of liver matrix remodeling: an enzyme-linked immunosorbent assay (ELISA) detecting a MMP generated type I collagen neo-epitope (C1M).
    Leeming Dj; He Y; Veidal S; Nguyen Q; Larsen D; Koizumi M; Segovia-Silvestre T; Zhang C; Zheng Q; Sun S; Cao Y; Barkholt V; Hägglund P; Bay-Jensen A; Qvist P; Karsdal M
    Biomarkers; 2011 Nov; 16(7):616-28. PubMed ID: 21988680
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New Concepts on Pathogenesis and Diagnosis of Liver Fibrosis; A Review Article.
    Ebrahimi H; Naderian M; Sohrabpour AA
    Middle East J Dig Dis; 2016 Jul; 8(3):166-178. PubMed ID: 27698966
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biglycan fragmentation in pathologies associated with extracellular matrix remodeling by matrix metalloproteinases.
    Genovese F; Barascuk N; Larsen L; Larsen MR; Nawrocki A; Li Y; Zheng Q; Wang J; Veidal SS; Leeming DJ; Karsdal MA
    Fibrogenesis Tissue Repair; 2013 May; 6(1):9. PubMed ID: 23635022
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fibrosis is not just fibrosis - basement membrane modelling and collagen metabolism differs between hepatitis B- and C-induced injury.
    Nielsen MJ; Karsdal MA; Kazankov K; Grønbaek H; Krag A; Leeming DJ; Schuppan D; George J
    Aliment Pharmacol Ther; 2016 Dec; 44(11-12):1242-1252. PubMed ID: 27696451
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum markers for hepatic fibrosis in alcoholic liver disease: which is the best marker, type III procollagen, type IV collagen, laminin, tissue inhibitor of metalloproteinase, or prolyl hydroxylase?
    Tsutsumi M; Takase S; Urashima S; Ueshima Y; Kawahara H; Takada A
    Alcohol Clin Exp Res; 1996 Dec; 20(9):1512-7. PubMed ID: 8986196
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The neo-epitope specific PRO-C3 ELISA measures true formation of type III collagen associated with liver and muscle parameters.
    Nielsen MJ; Nedergaard AF; Sun S; Veidal SS; Larsen L; Zheng Q; Suetta C; Henriksen K; Christiansen C; Karsdal MA; Leeming DJ
    Am J Transl Res; 2013; 5(3):303-15. PubMed ID: 23634241
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Invasive and non-invasive monitoring of hepatitis C virus-induced liver fibrosis: alternatives or complements?
    Olga OZ; Nikolai DY
    Curr Pharm Biotechnol; 2003 Jun; 4(3):195-209. PubMed ID: 12769763
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Collagen biology and non-invasive biomarkers of liver fibrosis.
    Karsdal MA; Daniels SJ; Holm Nielsen S; Bager C; Rasmussen DGK; Loomba R; Surabattula R; Villesen IF; Luo Y; Shevell D; Gudmann NS; Nielsen MJ; George J; Christian R; Leeming DJ; Schuppan D
    Liver Int; 2020 Apr; 40(4):736-750. PubMed ID: 31997561
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Non-invasive diagnosis of advanced fibrosis and cirrhosis.
    Sharma S; Khalili K; Nguyen GC
    World J Gastroenterol; 2014 Dec; 20(45):16820-30. PubMed ID: 25492996
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Noninvasive biochemical markers of liver fibrosis.
    Grigorescu M
    J Gastrointestin Liver Dis; 2006 Jun; 15(2):149-59. PubMed ID: 16802010
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potential role of noninvasive biomarkers during liver fibrosis.
    Kaur N; Goyal G; Garg R; Tapasvi C; Chawla S; Kaur R
    World J Hepatol; 2021 Dec; 13(12):1919-1935. PubMed ID: 35069998
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New challenges in hepatic fibrosis.
    Clément B; Loréal O; Levavasseur F; Guillouzo A
    J Hepatol; 1993 Apr; 18(1):1-4. PubMed ID: 8340600
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum connective tissue markers as predictors of advanced fibrosis in patients with chronic hepatitis B and D.
    Seven G; Karatayli SC; Köse SK; Yakut M; Kabaçam G; Törüner M; Heper AO; Voelker M; Erden E; Bozdayi AM; Uzunalımoğlu O; Bozkaya H; Yurdaydin C; Schuppan D
    Turk J Gastroenterol; 2011 Jun; 22(3):305-14. PubMed ID: 21805422
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The extracellular matrix in the kidney: a source of novel non-invasive biomarkers of kidney fibrosis?
    Genovese F; Manresa AA; Leeming DJ; Karsdal MA; Boor P
    Fibrogenesis Tissue Repair; 2014 Mar; 7(1):4. PubMed ID: 24678881
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Noninvasive assessment of liver fibrosis in patients with chronic hepatitis virus C].
    Guéchot J;
    Presse Med; 2006 Sep; 35(9 Pt 2):1317-26. PubMed ID: 16969327
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Hepatic fibrogenesis].
    Lee KS
    Korean J Gastroenterol; 2006 Nov; 48(5):297-305. PubMed ID: 17132917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.